BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Genetown

  Faron Updates on Bexmarilimab Development Program

  Faron Pharmaceuticals Ltd announces updated survival data from Phase I/II MATINS study investigating the safety and efficacy of bexmarilimab.

  February 23, 2022

   · 

  11 min read
• Drug Development

  Vicore takes major step towards a clinical platform company targeting AT2R - new molecule ready for phase 1

  Vicore Pharma Holding AB, a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor, announces advancing its first new chemical entity from the VP03 program to a first in human phase 1 trial.

  February 23, 2022

   · 

  2 min read
• Biotech Bay

  Mainz Biomed Provides U.S. Regulatory Review Update for ColoAlert

  Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced that its pre-submission filed with the U.S. Food & Drug Administration for ColoAlert has been accepted for review.

  February 23, 2022

   · 

  7 min read
• Business

  Complement Therapeutics Ltd raises EUR 5 Million Seed Financing by BGV and Forbion and appoints Dr Rafiq Hasan as CEO

  Complement Therapeutics Ltd, a preclinical stage University of Manchester spinout, announced the completion of its EUR 5 million seed financing round from BioGeneration Ventures and Forbion, two leading European venture capital firms.

  February 23, 2022

   · 

  3 min read
• Business

  Simcere Pharma (2096.HK) Announces a Positive Profit Alert

  Simcere Pharmaceutical Group Limited, the “Company”, together with its subsidiaries, the “Group”, announces a positive profit alert.

  February 23, 2022

   · 

  2 min read
• Business

  Genomics Company RevoluGen Announces the Appointment of Dr Annalisa Jenkins as Chair

  UK genomics company, RevoluGen Ltd., announces Dr Annalisa Jenkins, MBBS, FRCP, as Chair of the Board of Directors.

  February 23, 2022

   · 

  5 min read
• Drug Development

  Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma

  Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced interim data from a Phase II clinical trial of STP705, a siRNA therapeutic, for the treatment of cutaneous basal cell carcinoma.

  February 23, 2022

   · 

  5 min read
• Spago Nanomedical Publishes the Annual Report for 2021

  Spago Nanomedical’s annual report for 2021 is from available at the company’s website.

  February 23, 2022

   · 

  1 min read
• Policy

  Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine

  Sanofi and GSK announce that they intend to submit data from both their booster and Phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccine.

  February 23, 2022

   · 

  9 min read
• Business

  Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance

  Integra LifeSciences Holdings Corporation reported financial results for the fourth quarter and full year ended December 31, 2021, consistent with its preliminary revenue results announced on January 11, 2022.

  February 23, 2022

   · 

  27 min read